The life cycle of tertiary lymphoid structures in pancreatic cancer—a window of opportunity for immunotherapy - Takeaways - MDSpire

The life cycle of tertiary lymphoid structures in pancreatic cancer—a window of opportunity for immunotherapy

  • By

  • Yimin Chen

  • Yi Xiao

  • Taochun Zhang

  • Xinbo Wang

  • May 28, 2026

  • 0 min

Share

  • 1

    Pancreatic cancer has a poor prognosis due to low immunogenicity, strong immunosuppression, and dense tumor stroma.

  • 2

    Tertiary lymphoid structures (TLS) in the tumor microenvironment are associated with improved prognosis and patient outcomes.

  • 3

    The mechanisms governing TLS induction, maturation, maintenance, and resolution in pancreatic cancer remain poorly understood.

  • 4

    Clinical studies indicate that therapies can enhance TLS evolution, suggesting potential synergy in treatment.

  • 5

    There is a translational disconnect between TLS induction in preclinical models and limited clinical benefits in pancreatic cancer.

Original Source(s)

The life cycle of tertiary lymphoid structures in pancreatic cancer—a window of opportunity for immunotherapy

  • by Yimin Chen, Yi Xiao, Taochun Zhang, Xinbo Wang

  • May 28, 2026

Related Content

Case Report: A rare pediatric case of secretory carcinoma of the parotid gland with high-grade components misdiagnosed as pleomorphic adenoma

The onco-functional reorganization of language network underlying metaplasticity induced by gliomas

Association between adenomyosis subtypes and concurrent endometrial lesions: a propensity score-matched retrospective study